EPO and chronic hepatitis C virus infection: (Jea et al., 2007) Kobayashi et al. reported that ribavirin treatment in chronic hepatitis C patients induced anemia and may have led to increases in endogenous serum erythropoietin that in turn resulted in the stimulation of platelet production.